1
|
Kaufman DS, Shipley WU and Feldman AS:
Bladder cancer. Lancet. 374:239–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Kwak C, Ku JH, Park JY, Lee E, Lee SE and
Lee C: Initial tumor stage and grade as a predictive factor for
recurrence in patients with stage T1 grade 3 bladder cancer. J
Urol. 171:149–152. 2004. View Article : Google Scholar : PubMed/NCBI
|
4
|
Sternberg CN, Yagoda A, Scher HI, Watson
RC, Geller N, Herr HW, Morse MJ, Sogani PC, Vaughan ED, Bander N,
et al: Methotrexate, vinblastine, doxorubicin, and cisplatin for
advanced transitional cell carcinoma of the urothelium. Efficacy
and patterns of response and relapse. Cancer. 64:2448–2458. 1989.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Orren DK, Petersen LN and Bohr VA:
Persistent DNA damage inhibits S-phase and G2 progression and
results in apoptosis. Mol Biol Cell. 8:1129–1142. 1997. View Article : Google Scholar : PubMed/NCBI
|
6
|
Fujimoto K, Hosotani R, Doi R, Wada M, Lee
JU, Koshiba T, Miyamoto Y, Tsuji S, Nakajima S and Imamura M:
Induction of cell-cycle arrest and apoptosis by a novel
retinobenzoic-acid derivative, TAC-101, in human pancreatic-cancer
cells. Int J Cancer. 81:637–644. 1999. View Article : Google Scholar : PubMed/NCBI
|
7
|
Gamet-Payrastre L, Li P, Lumeau S, Cassar
G, Dupont MA, Chevolleau S, Gasc N, Tulliez J and Tercé F:
Sulforaphane, a naturally occurring isothiocyanate, induces cell
cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer
Res. 60:1426–1433. 2000.PubMed/NCBI
|
8
|
Nakagawa T, Zhu H, Morishima N, Li E, Xu
J, Yankner BA and Yuan J: Caspase-l2 mediates
endoplasmic-reticulum-specific apoptosis and cytotoxicity by
amyloid-beta. Nature. 403:98–103. 2000. View Article : Google Scholar : PubMed/NCBI
|
9
|
Srinivasula SM, Hegde R, Saleh A, Datta P,
Shiozaki E, Chai J, Lee RA, Robbins PD, Fernandes-Alnemri T, Shi Y
and Alnemri ES: A conserved XIAP-interaction motif in caspase-9 and
Smac/DIABLO regulates caspase activity and apoptosis. Nature.
409:112–116. 2001.
|
10
|
Degterev A, Boyce M and Yuan J: A decade
of caspases. Oncogene. 22:8543–8567. 2003. View Article : Google Scholar : PubMed/NCBI
|
11
|
Ziegler DS and Kung AL: Therapeutic
targeting of apoptosis pathways in cancer. Curr Opin Oncol.
20:97–103. 2008. View Article : Google Scholar : PubMed/NCBI
|
12
|
Jensen PR and Fenical W: Strategies for
the discovery of secondary metabolites from marine bacteria:
Ecological perspectives. Annu Rev Microbiol. 48:559–584. 1994.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Faulkner DJ: Marine natural products. Nat
Prod Rep. 18:1–49. 2001. View
Article : Google Scholar : PubMed/NCBI
|
14
|
McGlacken GP and Fairlamb IJ: 2-Pyrone
natural products and mimetics: Isolation, characterisation and
biological activity. Nat Prod Rep. 22:369–385. 2005. View Article : Google Scholar : PubMed/NCBI
|
15
|
Dickinson JM: Microbial pyran-2-ones and
dihydropyran-2-ones. Nat Prod Rep. 10:71–98. 1993. View Article : Google Scholar : PubMed/NCBI
|
16
|
Thaisrivongs S, Romero DL, Tommasi RA,
Janakiraman MN, Strohbach JW, Turner SR, Biles C, Morge RR, Johnson
PD, Aristoff PA, et al: Structure-based design of HIV protease
inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective,
nonpeptidic inhibitors. J Med Chem. 39:4630–4642. 1996. View Article : Google Scholar : PubMed/NCBI
|
17
|
Poppe SM, Slade DE, Chong KT, Hinshaw RR,
Pagano PJ, Markowitz M, Ho DD, Mo H, Gorman RR III, Dueweke TJ, et
al: Antiviral activity of the dihydropyrone PNU-140690, a new
nonpeptidic human immunodeficiency virus protease inhibitor.
Antimicrob Agents Chemother. 41:1058–1063. 1997.PubMed/NCBI
|
18
|
Turner SR, Strohbach JW, Tommasi RA,
Aristoff PA, Johnson PD, Skulnick HI, Dolak LA, Seest EP, Tomich
PK, Bohanon MJ, et al: Tipranavir (PNU-140690): A potent, orally
bioavailable nonpeptidic HIV protease inhibitor of the
5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class. J Med Chem.
41:3467–3476. 1998. View Article : Google Scholar : PubMed/NCBI
|
19
|
Trachootham D, Lu W, Ogasawara MA, Nilsa
RD and Huang P: Redox regulation of cell survival. Antioxid Redox
Signal. 10:1343–1374. 2008. View Article : Google Scholar : PubMed/NCBI
|
20
|
Hartwell LH and Weinert TA: Checkpoints:
Controls that ensure the order of cell cycle events. Science.
246:629–634. 1989. View Article : Google Scholar : PubMed/NCBI
|
21
|
Adams JM and Cory S: The Bcl-2 protein
family: Arbiters of cell survival. Science. 281:1322–1326. 1998.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Antonsson B and Martinou JC: The Bcl-2
protein family. Exp Cell Res. 256:50–57. 2000. View Article : Google Scholar : PubMed/NCBI
|
23
|
Salvesen GS and Dixit VM: Caspases:
Intracellular signaling by proteolysis. Cell. 91:443–446. 1997.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Rauh R, Kahl S, Boechzelt H, Bauer R,
Kaina B and Efferth T: Molecular biology of cantharidin in cancer
cells. Chin Med. 2:82007. View Article : Google Scholar : PubMed/NCBI
|
25
|
Ozben T: Oxidative stress and apoptosis:
Impact on cancer therapy. J Pharm Sci. 96:2181–2196. 2007.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Xiao L, Eto M and Kazanietz MG: ROCK
mediates phorbol ester-induced apoptosis in prostate cancer cells
via p21Cip1 upregulation and JNK. J Biol Chem. 284:29365–29375.
2009. View Article : Google Scholar : PubMed/NCBI
|
27
|
Lin KL, Su JC, Chien CM, Tseng CH, Chen
YL, Chang LS and Lin SR: Naphtho [1,2-b]furan-4,5-dione induces
apoptosis and S-phase arrest of MDA-MB-231 cells through JNK and
ERK signaling activation. Toxicol In Vitro. 24:61–70. 2010.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Choi YJ, Kim SY, Oh JM and Juhnn YS:
Stimulatory heterotrimeric G protein augments gamma ray-induced
apoptosis by up-regulation of Bak expression via CREB and AP-1 in
HL299 human lung cancer cells. Exp Mol Med. 41:592–600. 2009.
View Article : Google Scholar : PubMed/NCBI
|
29
|
An L, Dong GQ, Gao Q, Zhang Y, Hu LW, Li
JH and Liu Y: Effects of UVA on TNF-alpha, IL-1beta, and IL-10
expression levels in human keratinocytes and intervention studies
with an antioxidant and a JNK inhibitor. Photodermatol Photoimmunol
Photomed. 26:28–35. 2010. View Article : Google Scholar : PubMed/NCBI
|